| 000 | 01595 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513184520.0 | ||
| 264 | 0 | _c19990819 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0049-8254 | ||
| 024 | 7 |
_a10.1080/004982599238579 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcKillop, D | |
| 245 | 0 | 0 |
_aPreclinical and in vitro assessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions. _h[electronic resource] |
| 260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cApr 1999 |
||
| 300 |
_a395-408 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xdrug effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacology |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aPentobarbital _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
| 700 | 1 | _aBack, D J | |
| 700 | 1 | _aMcCormick, A D | |
| 700 | 1 | _aEvans, J A | |
| 700 | 1 | _aTjia, J | |
| 773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 29 _gno. 4 _gp. 395-408 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/004982599238579 _zAvailable from publisher's website |
| 999 |
_c10333473 _d10333473 |
||